Tag: metabolic syndrome

Metabolic syndrome (MetS) is an important public health problem worldwide, and its prevalence is increasing [1, 2]. Patients with MetS are at higher risk for many long-term complications, including micro- and macro-vascular complications [2]. This is particularly relevant in patients with type 2 diabetes mellitus (T2DM), who are at even greater cardiovascular risk [3].

Obesity is associated with a higher risk of type 2 diabetes and lipid disorders as well as cardiovascular diseases, cancer and musculoskeletal disorders. The risk of these disorders, however, has been found to be significantly lower among a small group of obese individuals, known as obese but metabolically healthy.

Current smoking, dyslipidemia, elevated blood pressure, overweight and obesity remain as major causes of morbidity and mortality from cardiovascular disease, thrombosis, stroke, kidney disease, and diabetes mellitus throughout the world [1, 2]. Insulin resistance is associated with obesity, glucose intolerance or diabetes, hypertension, dyslipidemia, and cardiovascular disease. Constellation of these risk factors is called metabolic syndrome (MetS) [1–3]...